These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16832105)

  • 1. Infantile onset myasthenia gravis with MuSK antibodies.
    Murai H; Noda T; Himeno E; Kawano Y; Ohyagi Y; Shiraishi H; Motomura M; Kira J
    Neurology; 2006 Jul; 67(1):174. PubMed ID: 16832105
    [No Abstract]   [Full Text] [Related]  

  • 2. MuSK-antibody positive pure ocular myasthenia gravis.
    Hanisch F; Eger K; Zierz S
    J Neurol; 2006 May; 253(5):659-60. PubMed ID: 16311895
    [No Abstract]   [Full Text] [Related]  

  • 3. MuSK-antibody positive myasthenia gravis: questions from the clinic.
    Sanders DB; Juel VC
    J Neuroimmunol; 2008 Sep; 201-202():85-9. PubMed ID: 18684517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness.
    Casasnovas C; Povedano M; Jaumà S; Montero J; Martínez-Matos JA
    Neuromuscul Disord; 2007 Jul; 17(7):544-6. PubMed ID: 17533129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged B-cell depletion in MuSK myasthenia gravis following rituximab treatment.
    Yi JS; Decroos EC; Sanders DB; Weinhold KJ; Guptill JT
    Muscle Nerve; 2013 Dec; 48(6):992-3. PubMed ID: 24006142
    [No Abstract]   [Full Text] [Related]  

  • 6. Myasthenia gravis--a rare presentation with tongue atrophy and fasciculation.
    Burch J; Warren-Gash C; Ingham V; Patel M; Bennett D; Chaudhuri KR
    Age Ageing; 2006 Jan; 35(1):87-8. PubMed ID: 16364941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MuSK myasthenia gravis presenting with Epstein-Barr virus-associated mononucleosis and immune-mediated diabetes mellitus.
    Bhibhatbhan A; Kline G; Vincent A; Toth C
    Muscle Nerve; 2007 Aug; 36(2):264-6. PubMed ID: 17266132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple Furrowed Atrophic Tongue of Myasthenia Gravis.
    Young NP; Sorenson EJ; Milone M; Harper CM
    J Clin Neuromuscul Dis; 2017 Sep; 19(1):47-48. PubMed ID: 28827490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-MuSK antibodies: correlation with myasthenia gravis severity.
    Bartoccioni E; Scuderi F; Minicuci GM; Marino M; Ciaraffa F; Evoli A
    Neurology; 2006 Aug; 67(3):505-7. PubMed ID: 16894117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging of facial muscles.
    Farrugia ME; Bydder GM; Francis JM; Robson MD
    Clin Radiol; 2007 Nov; 62(11):1078-86. PubMed ID: 17920867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe neonatal myasthenia due to maternal anti-MuSK antibodies.
    Béhin A; Mayer M; Kassis-Makhoul B; Jugie M; Espil-Taris C; Ferrer X; Chatenoud L; Laforêt P; Eymard B
    Neuromuscul Disord; 2008 Jun; 18(6):443-6. PubMed ID: 18434154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Seronegative" anti-MUSK positive myasthenia gravis presenting during pregnancy.
    Terrero A; Ramírez-Rivera J
    Bol Asoc Med P R; 2006; 98(3):210-2. PubMed ID: 19610560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative EMG of facial muscles in myasthenia patients with MuSK antibodies.
    Farrugia ME; Kennett RP; Hilton-Jones D; Newsom-Davis J; Vincent A
    Clin Neurophysiol; 2007 Feb; 118(2):269-77. PubMed ID: 17157556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to therapy in myasthenia gravis with anti-MuSK antibodies.
    Evoli A; Bianchi MR; Riso R; Minicuci GM; Batocchi AP; Servidei S; Scuderi F; Bartoccioni E
    Ann N Y Acad Sci; 2008; 1132():76-83. PubMed ID: 18567856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis.
    Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y
    J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis experimentally induced with muscle-specific kinase.
    Shigemoto K; Kubo S; Jie C; Hato N; Abe Y; Ueda N; Kobayashi N; Kameda K; Mominoki K; Miyazawa A; Ishigami A; Matsuda S; Maruyama N
    Ann N Y Acad Sci; 2008; 1132():93-8. PubMed ID: 18096854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
    Wolfe GI; Oh SJ
    Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.